These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8014051)

  • 41. Cryofibrinogenaemia with vasculitis: a new overlap syndrome causing severe leg ulcers and digital necrosis in rheumatoid arthritis?
    Soyfoo MS; Couturier B; Cogan E
    Rheumatology (Oxford); 2010 Dec; 49(12):2455-7. PubMed ID: 20659917
    [No Abstract]   [Full Text] [Related]  

  • 42. Association between capillaroscopy, haemorheological variables and plasma proteins in patients bearing Raynaud's phenomenon.
    Spengler MI; Svetaz MJ; Leroux MB; Leiva ML; Bottai HM
    Clin Hemorheol Microcirc; 2004; 30(1):17-24. PubMed ID: 14967879
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cryofibrinogenemia associated with polyarteritis nodosa.
    Shimbo J; Miwa A; Aoki K
    Clin Rheumatol; 2006 Jul; 25(4):562-3. PubMed ID: 16292471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasmapheresis in Raynaud's phenomenon in systemic sclerosis: a microcirculatory study.
    Jacobs MJ; Jörning PJ; Van Rhede van der Kloot EJ; Kitslaar PJ; Lemmens HA; Slaaf DW; Reneman RS
    Int J Microcirc Clin Exp; 1991 Feb; 10(1):1-11. PubMed ID: 2019479
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cryofibrinogenemia].
    Saadoun D; Musset L; Cacoub P
    Rev Med Interne; 2011 May; 32(5):287-91. PubMed ID: 20561722
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cryofibrinogenaemia and acute gangrene in systemic sclerosis.
    Barrett MC; Prendiville JS; Pardy BJ; Cream JJ
    Postgrad Med J; 1986 Oct; 62(732):935-6. PubMed ID: 3774725
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cryofibrinogenemia: new insights into clinical and pathogenic features.
    Saadoun D; Elalamy I; Ghillani-Dalbin P; Sene D; Delluc A; Cacoub P
    Am J Med; 2009 Dec; 122(12):1128-35. PubMed ID: 19958891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Familial presence of primary cryofibrinogenaemia, a report of three cases.
    Wulffraat N; Meyer KJ; Zegers BJ; Kuis W
    Br J Rheumatol; 1996 Jan; 35(1):102-4. PubMed ID: 8624616
    [No Abstract]   [Full Text] [Related]  

  • 49. It Is Just a Rash They Said! Acute Skin Manifestation in a Patient With Vasculitis in Rural Hospitals.
    Sawalha K; Kunnumpurath A; Singh S; Kamoga GR
    J Investig Med High Impact Case Rep; 2020; 8():2324709620966446. PubMed ID: 33090049
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amantadine-Induced Livedo Racemosa.
    Criado PR; Alavi A; Valente NY; Sotto MN
    Int J Low Extrem Wounds; 2016 Mar; 15(1):78-81. PubMed ID: 26338517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Significance of monitoring histamine serum levels, cryoglobulins and complement titers during cold tests in patients with cold allergy and Raynaud's phenomenon].
    Despotović N; Paranos S; Bojović I; Milovanović M; Dmitrović V; Rezić T; Vidanović M
    Glas Srp Akad Nauka Med; 1994; (44):55-61. PubMed ID: 7590415
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Part II: Cutaneous manifestations of peripheral vascular disease.
    Raja A; Karch J; Shih AF; De La Garza H; De Zepeda Diaz AJ; Maymone MBC; Phillips TJ; Secemsky E; Vashi N
    J Am Acad Dermatol; 2023 Aug; 89(2):211-226. PubMed ID: 35504485
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia.
    Browning CE; Callen JP
    Arch Dermatol; 2006 Jan; 142(1):75-8. PubMed ID: 16415390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of severe Raynaud's phenomenon and ischemic ulcerations with tissue plasimogen activator.
    Lakshminarayanan S; Vázquez-Abad D; Maestrello SJ; Waterman JR
    Clin Exp Rheumatol; 1999; 17(2):260. PubMed ID: 10342058
    [No Abstract]   [Full Text] [Related]  

  • 55. Purpura and recurrent ulcers on the lower extremities. Essential cryofibrinogenemia.
    Klein AD; Kerdel FA
    Arch Dermatol; 1991 Jan; 127(1):115, 118. PubMed ID: 1986695
    [No Abstract]   [Full Text] [Related]  

  • 56. Reversal of microvascular abnormalities in a successfully treated case of leukocytoclastic vasculitis.
    Kitchens CS
    Johns Hopkins Med J; 1980 Sep; 147(3):97-101. PubMed ID: 7412072
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Livedo racemosa generalisata in atrial myxoma].
    Rambusch EG; Musholt P; Weissenborn K; Kiehl P; Deicher H
    Z Rheumatol; 1996; 55(1):58-62. PubMed ID: 8868151
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cutaneous lesions in cryofibrinogenemia.
    Ireland TA; Werner DA; Rietschel RL; Patterson JH; Spraker MK
    J Pediatr; 1984 Jul; 105(1):67-9. PubMed ID: 6737150
    [No Abstract]   [Full Text] [Related]  

  • 59. Stanozolol in treatment of leg ulcers due to cryofibrinogenaemia.
    Falanga V; Kirsner RS; Eaglstein WH; Katz MH; Kerdel FA
    Lancet; 1991 Aug; 338(8763):347-8. PubMed ID: 1677702
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Cold labile serum and plasma proteins: clinical and diagnostic significance of cryoglobulins, cryofibrinogen and cold agglutinins].
    Weiner SM; Röther E; Weber S; Schlesier M; Berthold H; Peter HH
    Immun Infekt; 1994 Oct; 22(5):169-76. PubMed ID: 7982712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.